APA (7th ed.) Citation

Han, Y. (2023). Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles.

Chicago Style (17th ed.) Citation

Han, Yang. Using TGF-β1 Biology in Radioiodine Refractory Differentiated Thyroid Cancer to Re-establish Sodium Iodide Symporter (NIS) Expression Using Engineered Mesenchymal Stem Cells as Therapy Vehicles. München, 2023.

MLA (9th ed.) Citation

Han, Yang. Using TGF-β1 Biology in Radioiodine Refractory Differentiated Thyroid Cancer to Re-establish Sodium Iodide Symporter (NIS) Expression Using Engineered Mesenchymal Stem Cells as Therapy Vehicles. 2023.